Boundless Bio, Inc. Common Stock (BOLD) |
10.66 0.65 (6.49%) 04-23 16:00 |
Open: | 9.97 |
High: | 10.905 |
Low: | 9.97 |
Volume: | 111,682 |
Market Cap: | 237(M) |
PE Ratio: | 0 |
Exchange: | Nasdaq |
Industry: | Biotechnology |
Sector: | Healthcare |
Technical analysis | ||||
sell | buy |
Resistance 2: | 15.24 |
Resistance 1: | 13.18 |
Pivot price: | 11.57 |
Support 1: | 9.84 |
Support 2: | 8.19 |
52w High: | 15.24 |
52w Low: | 9.83 |
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California.
EPS | 0.000 |
Book Value | 0.000 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | 0.00 |
Operating Margin (%) | 0.00 |
Return on Assets (ttm) | -33.1 |
Return on Equity (ttm) | -52.9 |
Thu, 04 Apr 2024
Boundless Bio insiders purchase $3.2m in stock By Investing.com - Investing.com
Thu, 04 Apr 2024
Ra capital funds buy Boundless Bio shares worth $5 million - Investing.com
Thu, 28 Mar 2024
Boundless Bio raises $100m as IPO market rouses - Pharmaceutical Technology
Thu, 28 Mar 2024
Latham Watkins Advises Boundless Bio on Initial Public Offering - Latham & Watkins LLP -
Wed, 27 Mar 2024
Boundless Bio Announces Pricing of Initial Public Offering - Business Wire
Mon, 25 Mar 2024
Boundless Bio Readies $94 Million U.S. IPO Effort (NASDAQ:BOLD) - Seeking Alpha
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |